InvestorsHub Logo
Followers 6
Posts 1257
Boards Moderated 0
Alias Born 06/14/2009

Re: None

Thursday, 09/03/2020 8:22:27 AM

Thursday, September 03, 2020 8:22:27 AM

Post# of 5807
With all the good news and the price let down. It seems everyone focused on the Covid 19 test panel- which in itself is a good thing for T2 to have. However, that is not their core business to the slightest, it's just an opportunity for them to sell more of the T2 machines, so that they can have a good number of hospitals hooked on to it. They make more money on the slew of test panels that can run on the same machine, from early diagnosing sepsis (including on critically ill covid 19 patients) to testing for many other infectious diseases and antibiotic resistance screenings.Then the big elephant in the room that no one is talking about is the "NEW" test panel they are developing for Bio-threats (which they have to still get FDA approval on and their research is supported by Govt funding). Think about T2 getting a Defense contract for that panel when it comes out. The bio-threat panel alone will make them huge, as it is a big unmet need and when thinking of the many crazies going on around the world; if approved, such a quick test for those possible biological weapon pathogens will be a game changer....GOOD LUCK LONGS
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTOO News